Analytics, not advice. Rankings and scores describe past performance and are not recommendations.
Uncategorised
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option
ITI Mutual Fund · Managed by Nilay Dalal; Animesh Singh
82strong
Latest NAV
₹19.8280
as of 18 Aug 2026
AUM
—
Expense ratio
0.95%
as of 30 Jun 2026
Inception
14 May 2026
FundScore
82/100strong
Rank #190 of 1015 · top 18%
A daily percentile of this fund’s past performance within its SEBI category — analytics, not advice, and not a prediction or recommendation.
Trailing returns
Annualised returns to the latest NAV. Refreshed nightly.
1M
3.45%
3M
7.77%
6M
19.31%
1Y
12.22%
3Y CAGR
20.23%
5Y CAGR
—
Since incep.
15.42%
Fund details
- Fund manager
- Nilay Dalal; Animesh Singh
- Riskometer
- Very High Risk
- Type
- Open Ended
- Portfolio turnover
- 53%
- Volatility (3Y)
- 13.6%
- Rating (external)
- —
Investment objective
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.
NAV history
Zoom and pan · ranges from 1M to since-inception.
Rolling returns
Every 30-day step. The true distribution, not cherry-picked.
Rank history
Percentile within category over the last 2 years.
FundScore components
Pro-only breakdown of consistency, recency, and volatility scores.
Upgrade to Pro to see the raw drivers behind this scheme's FundScore label.
Pro
Stock holdings
Latest portfolio disclosure for this scheme.
No data yet
This fund hasn't disclosed a portfolio snapshot yet.